<![CDATA[Pfizer,Biontech Omikron BA.4/BA.5 vaccine &lpar;nød&rpar;godkendt,FDA]]>"Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older" https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-fda-emergency-use-authorization

]]>https://dev.proinvestor.com/forum/topic/444236/pfizerbiontech-omikron-ba4ba5-vaccine-lparndrpargodkendtfdaRSS for NodeTue, 30 Jun 2026 08:16:04 GMTWed, 31 Aug 2022 17:54:05 GMT60<![CDATA[Reply to Pfizer,Biontech Omikron BA.4/BA.5 vaccine &lpar;nød&rpar;godkendt,FDA on Thu, 01 Sep 2022 11:35:02 GMT]]>First adapted COVID-19 booster vaccines recommended for approval in the EU.

https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu

]]>https://dev.proinvestor.com/forum/post/9477038https://dev.proinvestor.com/forum/post/9477038Thu, 01 Sep 2022 11:35:02 GMT<![CDATA[Reply to Pfizer,Biontech Omikron BA.4/BA.5 vaccine &lpar;nød&rpar;godkendt,FDA on Wed, 31 Aug 2022 18:01:29 GMT]]>EMA CHMP har møde i morgen om Omikron BA.1 vacciner fra Moderna og fra Pfizer/Biontech. "The aim of the meeting is to conclude the evaluation of the two applications, if possible."

https://www.ema.europa.eu/en/events/extraordinary-meeting-committee-medicinal-products-human-use-chmp-1-september-2022

]]>https://dev.proinvestor.com/forum/post/9477040https://dev.proinvestor.com/forum/post/9477040Wed, 31 Aug 2022 18:01:29 GMT